Global Rare Disease Drug Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 161397
- Pages: 150
-
Format:
Summary
The global Rare Disease Drug market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
>1
0.65 1
<0.1
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 Rare Disease Drug of Research
1.1.1 Definition
1.1.2 Specifications of Rare Disease Drug
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 >1 Overview
1.2.1.2 0.65 1 Overview
1.2.1.3 <0.1 Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Hospital Pharmacies
1.3.1.2 Speciality Pharmacies
1.3.1.3 Retail pharmacies
1.3.1.4 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 >1 Market Size 2018-2023
3.1.1.1 Global >1 Market Size and Growth Rate 2018-2023
3.1.1.2 Global >1 Market Size by Region 2018-2023
3.1.2 0.65 1 Market Size 2018-2023
3.1.2.1 Global 0.65 1 Market Size and Growth Rate 2018-2023
3.1.2.2 Global 0.65 1 Market Size by Region 2018-2023
3.1.3 <0.1 Market Size 2018-2023
3.1.3.1 Global <0.1 Market Size and Growth Rate 2018-2023
3.1.3.2 Global <0.1 Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 >1 Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global >1 Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global >1 Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 0.65 1 Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global 0.65 1 Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global 0.65 1 Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 <0.1 Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global <0.1 Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global <0.1 Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Hospital Pharmacies Market Size 2018-2023
4.1.1.1 Global Hospital Pharmacies Market Size and Growth Rate 2018-2023
4.1.1.2 Global Hospital Pharmacies Market Size by Region 2018-2023
4.1.2 Speciality Pharmacies Market Size 2018-2023
4.1.2.1 Global Speciality Pharmacies Market Size and Growth Rate 2018-2023
4.1.2.2 Global Speciality Pharmacies Market Size by Region 2018-2023
4.1.3 Retail pharmacies Market Size 2018-2023
4.1.3.1 Global Retail pharmacies Market Size and Growth Rate 2018-2023
4.1.3.2 Global Retail pharmacies Market Size by Region 2018-2023
4.1.4 Others Market Size 2018-2023
4.1.4.1 Global Others Market Size and Growth Rate 2018-2023
4.1.4.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Hospital Pharmacies Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Hospital Pharmacies Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Hospital Pharmacies Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Speciality Pharmacies Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Speciality Pharmacies Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Speciality Pharmacies Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Retail pharmacies Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Retail pharmacies Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Retail pharmacies Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Others Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global Rare Disease Drug Market Competition
7.1.1 Global Rare Disease Drug Market by Companies
7.1.2 Global Rare Disease Drug Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Novartis AG
8.1.1 Novartis AG Company Profile
8.1.2 Novartis AG Product Portfolio
8.1.3 Novartis AG Business Performance
8.1.4 Novartis AG Development Overview
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company Company Profile
8.2.2 Bristol-Myers Squibb Company Product Portfolio
8.2.3 Bristol-Myers Squibb Company Business Performance
8.2.4 Bristol-Myers Squibb Company Development Overview
8.3 Celgene Corporation
8.3.1 Celgene Corporation Company Profile
8.3.2 Celgene Corporation Product Portfolio
8.3.3 Celgene Corporation Business Performance
8.3.4 Celgene Corporation Development Overview
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 F. Hoffmann-La Roche Ltd. Company Profile
8.4.2 F. Hoffmann-La Roche Ltd. Product Portfolio
8.4.3 F. Hoffmann-La Roche Ltd. Business Performance
8.4.4 F. Hoffmann-La Roche Ltd. Development Overview
8.5 Pfizer, Inc.
8.5.1 Pfizer, Inc. Company Profile
8.5.2 Pfizer, Inc. Product Portfolio
8.5.3 Pfizer, Inc. Business Performance
8.5.4 Pfizer, Inc. Development Overview
8.6 Sanofi S.A.
8.6.1 Sanofi S.A. Company Profile
8.6.2 Sanofi S.A. Product Portfolio
8.6.3 Sanofi S.A. Business Performance
8.6.4 Sanofi S.A. Development Overview
8.7 Alexion Pharmaceuticals, Inc.
8.7.1 Alexion Pharmaceuticals, Inc. Company Profile
8.7.2 Alexion Pharmaceuticals, Inc. Product Portfolio
8.7.3 Alexion Pharmaceuticals, Inc. Business Performance
8.7.4 Alexion Pharmaceuticals, Inc. Development Overview
8.8 Eli Lilly and Company
8.8.1 Eli Lilly and Company Company Profile
8.8.2 Eli Lilly and Company Product Portfolio
8.8.3 Eli Lilly and Company Business Performance
8.8.4 Eli Lilly and Company Development Overview
8.9 Novo Nordisk A/S
8.9.1 Novo Nordisk A/S Company Profile
8.9.2 Novo Nordisk A/S Product Portfolio
8.9.3 Novo Nordisk A/S Business Performance
8.9.4 Novo Nordisk A/S Development Overview
8.10 AstraZeneca
8.10.1 AstraZeneca Company Profile
8.10.2 AstraZeneca Product Portfolio
8.10.3 AstraZeneca Business Performance
8.10.4 AstraZeneca Development Overview
8.11 Eisai Co., Ltd.
8.11.1 Eisai Co., Ltd. Company Profile
8.11.2 Eisai Co., Ltd. Product Portfolio
8.11.3 Eisai Co., Ltd. Business Performance
8.11.4 Eisai Co., Ltd. Development Overview
8.12 Daiichi Sankyo Company Limited
8.12.1 Daiichi Sankyo Company Limited Company Profile
8.12.2 Daiichi Sankyo Company Limited Product Portfolio
8.12.3 Daiichi Sankyo Company Limited Business Performance
8.12.4 Daiichi Sankyo Company Limited Development Overview
8.13 Bayer AG
8.13.1 Bayer AG Company Profile
8.13.2 Bayer AG Product Portfolio
8.13.3 Bayer AG Business Performance
8.13.4 Bayer AG Development Overview
8.14 GlaxoSmithKline
8.14.1 GlaxoSmithKline Company Profile
8.14.2 GlaxoSmithKline Product Portfolio
8.14.3 GlaxoSmithKline Business Performance
8.14.4 GlaxoSmithKline Development Overview
8.15 Merck & Co., Inc.
8.15.1 Merck & Co., Inc. Company Profile
8.15.2 Merck & Co., Inc. Product Portfolio
8.15.3 Merck & Co., Inc. Business Performance
8.15.4 Merck & Co., Inc. Development Overview
8.16 Johnson & Johnson
8.16.1 Johnson & Johnson Company Profile
8.16.2 Johnson & Johnson Product Portfolio
8.16.3 Johnson & Johnson Business Performance
8.16.4 Johnson & Johnson Development Overview
8.17 Biogen, Inc.
8.17.1 Biogen, Inc. Company Profile
8.17.2 Biogen, Inc. Product Portfolio
8.17.3 Biogen, Inc. Business Performance
8.17.4 Biogen, Inc. Development Overview
8.18 Shire
8.18.1 Shire Company Profile
8.18.2 Shire Product Portfolio
8.18.3 Shire Business Performance
8.18.4 Shire Development Overview
8.19 Amgen, Inc.
8.19.1 Amgen, Inc. Company Profile
8.19.2 Amgen, Inc. Product Portfolio
8.19.3 Amgen, Inc. Business Performance
8.19.4 Amgen, Inc. Development Overview
8.20 Deciphera
8.20.1 Deciphera Company Profile
8.20.2 Deciphera Product Portfolio
8.20.3 Deciphera Business Performance
8.20.4 Deciphera Development Overview
8.21 Atara Biotherapeutics
8.21.1 Atara Biotherapeutics Company Profile
8.21.2 Atara Biotherapeutics Product Portfolio
8.21.3 Atara Biotherapeutics Business Performance
8.21.4 Atara Biotherapeutics Development Overview
8.22 ProQR
8.22.1 ProQR Company Profile
8.22.2 ProQR Product Portfolio
8.22.3 ProQR Business Performance
8.22.4 ProQR Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
